Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Osherov

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Expert Review of Clinical Pharmacology|August 15, 2017
Daclizumab for the treatment of adults with relapsing forms of multiple sclerosisMichael Osherov, Ron Milo
American Journal of Otolaryngology|April 14, 2018
In whom does horizontal canal BPPV recur?L Pollak, R Huna-Baron, Michael Osherov, et al.
The Neuroradiology Journal|January 4, 2021
Association between cervical disc disease and lesions of multiple sclerosisMarwan Alkrenawi, Michael Osherov, Azaria Simonovich, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 8, 2017
Mycosis fungoides - A cutaneous lymphoproliferative disorder in a patient treated with fingolimod for multiple sclerosisZeev Nitsan, Nihal Kucuk, Shmuel Appel, et al.
Brain and Behavior|December 15, 2015
Magnetic resonance brain imaging in patients with visual vertigoLea Pollak, Michael Osherov, Nadav Berkovitz, et al.
Multiple Sclerosis and Related Disorders|April 26, 2023
The consequences of switching from Gilenya® to generics for fingolimodLeslie Menendez, Michael Osherov, Zeev Nitsan, et al.
Journal of the Neurological Sciences|September 2, 2020
Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemicMaryam Sharifian-Dorche, Philippe Huot, Michael Osherov, et al.
Journal of Neurology|May 6, 2020
Familial Creutzfeldt-Jakob disease homozygous to the E200K mutation: clinical characteristics and disease courseZeev Nitsan, Oren S Cohen, Joab Chapman, et al.
Multiple Sclerosis and Related Disorders|October 6, 2023
Dual positivity for anti-MOG and oligoclonal bands: Unveiling unique clinical profiles and implicationsEsther Ganelin-Cohen, Shahar Shelly, Yael Schiller, et al.
Plos Biology|September 8, 2025
The immune receptor SLAMF5 regulates myeloid-cell mediated neuroinflammation in multiple sclerosisLaura Bellassen, Keren David, Bar Lampert, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Review of Clinical Pharmacology|August 15, 2017
Daclizumab for the treatment of adults with relapsing forms of multiple sclerosisMichael Osherov, Ron Milo
American Journal of Otolaryngology|April 14, 2018
In whom does horizontal canal BPPV recur?L Pollak, R Huna-Baron, Michael Osherov, et al.
The Neuroradiology Journal|January 4, 2021
Association between cervical disc disease and lesions of multiple sclerosisMarwan Alkrenawi, Michael Osherov, Azaria Simonovich, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 8, 2017
Mycosis fungoides - A cutaneous lymphoproliferative disorder in a patient treated with fingolimod for multiple sclerosisZeev Nitsan, Nihal Kucuk, Shmuel Appel, et al.
Brain and Behavior|December 15, 2015
Magnetic resonance brain imaging in patients with visual vertigoLea Pollak, Michael Osherov, Nadav Berkovitz, et al.
Multiple Sclerosis and Related Disorders|April 26, 2023
The consequences of switching from Gilenya® to generics for fingolimodLeslie Menendez, Michael Osherov, Zeev Nitsan, et al.
Journal of the Neurological Sciences|September 2, 2020
Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemicMaryam Sharifian-Dorche, Philippe Huot, Michael Osherov, et al.
Journal of Neurology|May 6, 2020
Familial Creutzfeldt-Jakob disease homozygous to the E200K mutation: clinical characteristics and disease courseZeev Nitsan, Oren S Cohen, Joab Chapman, et al.
Multiple Sclerosis and Related Disorders|October 6, 2023
Dual positivity for anti-MOG and oligoclonal bands: Unveiling unique clinical profiles and implicationsEsther Ganelin-Cohen, Shahar Shelly, Yael Schiller, et al.
Plos Biology|September 8, 2025
The immune receptor SLAMF5 regulates myeloid-cell mediated neuroinflammation in multiple sclerosisLaura Bellassen, Keren David, Bar Lampert, et al.
Pageof 2